mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.004 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.004 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |